Sponsor pipeline

Chinese University of Hong Kong clinical trial pipeline

Get alerts when Chinese University of Hong Kong's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

19 trials changed in the last 30 days: 0 stopped, 8 with notable changes, 11 with minor changes only.

  2. Notable

    Primary completion pushed from Dec 15, 2024 to Dec 31, 2028

    Also in this update: Trial status changed: Unknown → Recruiting; Study completion pushed from Jun 15, 2025 to Dec 31, 2028

    Chinese University of Hong KongNot specified NCT05144152 Registry history

  4. Notable

    Primary completion pushed from Dec 1, 2025 to Dec 31, 2030

    Also in this update: Trial status changed: Unknown → Recruiting; Study completion pushed from Dec 31, 2025 to Dec 31, 2030

    Chinese University of Hong KongNot specified NCT05053945 Registry history

Show 11 trials with minor changes only
  3. Minor

    Trial completed

    Also in this update: Final enrollment: 160 participants (planned 120); Primary completion date changed from estimate of Nov 30, 2025 to Jun 30, 2025

    Chinese University of Hong KongNot specified NCT05797649 Registry history

  4. Minor

    Trial status changed: Unknown → Active, Not Recruiting

    Also in this update: Primary completion date changed from estimate of Jun 15, 2025 to May 7, 2025; Study completion pushed from Dec 31, 2025 to Dec 31, 2030

    Chinese University of Hong KongNot specified NCT05405673 Registry history

  7. Minor
    5 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-13 NCT07869992 Evaluate of the Use of Uromune as a Potential Non-antibiotic Prophylactic Strategy for… Not Yet Recruiting
2026-10-06 NCT07861815 Assessing the Feasibility of Using Methylene Blue in Identifying Ureters During… Phase 4 Not Yet Recruiting
2026-10-05 NCT07857980 Effects of School-Based Ignatian Examen Meditation on Well-Being, Gratitude, Hope, and… Not Yet Recruiting
2026-10-05 NCT07858227 Association Between Serum Progesterone Levels on Embryo Transfer Day and Clinical… Not Yet Recruiting
2026-10-02 NCT07854561 Combination Therapy of Romiplostim and Erythropoiesis-stimulating Agents Phase 2 Recruiting
2026-09-28 NCT07843719 Su2ura ESD Closure Pilot Study Not Yet Recruiting
2026-09-28 NCT07844252 A Novel Multi-functional Artificial Intelligence System on Treatment Efficacy and… Not Yet Recruiting
2026-09-23 NCT07835932 Randomised Controlled Trial of Fluorescent Urography Using Intravenous Methylene Blue… Phase 4 Not Yet Recruiting
2026-09-22 NCT07834528 Brain Heath Service for Prevention of AD Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
1
Phase 2
31
Phase 2/3
4
Phase 3
8
Phase 4
20
Not charted: 377 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 44

Prostate Cancer (19) · Stroke (18) · Heart Disease (16) · Colorectal Cancer (15) · Diabetes (15) · Depression (13) · Obesity (12) · Gastric Cancer (9) · Anxiety (8) · Bladder Cancer (8)

Get alerts when Chinese University of Hong Kong's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free